XML 105 R88.htm IDEA: XBRL DOCUMENT v3.8.0.1
Supplemental Guarantor Financial Information - Condensed Consolidating Statements of Cash Flow (Details) - USD ($)
$ in Millions
 8 Months Ended 12 Months Ended
Dec. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Operating Activities        
Cash (Used in) Provided by Operating Activities   $ 144.2 $ 188.8 $ 97.6
Investing Activities        
Capital expenditures   (43.2) (29.1) (70.4)
Acquisition of business, net of cash acquired   0.0 (175.0) 0.0
Proceeds from dispositions of property   0.1 3.2 7.8
Intercompany contributions   0.0 0.0 0.0
Cash Used in Investing Activities   (43.1) (200.9) (62.6)
Financing Activities        
Intercompany contributions   0.0 0.0 0.0
Line of credit facility proceeds   0.0 72.0 0.0
Line of credit facility repayments $ (72.0) 0.0 (72.0) 0.0
Debt repayments   0.0 0.0 (51.0)
Debt issuance costs   0.0 (0.9) 0.0
Purchase of treasury stock   (2.5) (0.9) (1.0)
Proceeds and excess tax benefits from the exercise of stock options   4.7 0.4 1.4
Cash Provided by (Used in) Financing Activities   2.2 (1.4) (50.6)
Effect of Exchange Rate on Cash and Cash Equivalents   2.7 (2.3) (3.9)
Increase (Decrease) in Cash and Cash Equivalents   106.0 (15.8) (19.5)
Cash and Cash Equivalents - Beginning of Year   113.7 129.5 149.0
Cash and Cash Equivalents - End of Year 113.7 219.7 113.7 129.5
Eliminations        
Operating Activities        
Cash (Used in) Provided by Operating Activities   0.0 (1.7) (2.5)
Investing Activities        
Capital expenditures   0.0 0.0 0.0
Acquisition of business, net of cash acquired     0.0  
Proceeds from dispositions of property   0.0 0.0 0.0
Intercompany contributions   98.8 174.7 11.9
Cash Used in Investing Activities   98.8 174.7 11.9
Financing Activities        
Intercompany contributions   (98.8) (170.5) (11.9)
Line of credit facility proceeds     0.0  
Line of credit facility repayments     0.0  
Debt repayments       0.0
Debt issuance costs     0.0  
Purchase of treasury stock   0.0 0.0 0.0
Proceeds and excess tax benefits from the exercise of stock options   0.0 0.0 0.0
Cash Provided by (Used in) Financing Activities   (98.8) (170.5) (11.9)
Effect of Exchange Rate on Cash and Cash Equivalents   0.0 0.0 0.0
Increase (Decrease) in Cash and Cash Equivalents   0.0 2.5 (2.5)
Cash and Cash Equivalents - Beginning of Year   0.0 (2.5) 0.0
Cash and Cash Equivalents - End of Year 0.0 0.0 0.0 (2.5)
Parent | Reportable legal entities        
Operating Activities        
Cash (Used in) Provided by Operating Activities   (43.3) (33.0) (44.7)
Investing Activities        
Capital expenditures   0.0 0.0 0.0
Acquisition of business, net of cash acquired     (175.0)  
Proceeds from dispositions of property   0.0 0.0 0.0
Intercompany contributions   0.0 0.5 39.9
Cash Used in Investing Activities   0.0 (174.5) 39.9
Financing Activities        
Intercompany contributions   101.4 170.8 46.5
Line of credit facility proceeds     72.0  
Line of credit facility repayments     (72.0)  
Debt repayments       (51.0)
Debt issuance costs     (0.9)  
Purchase of treasury stock   (2.5) (0.9) (1.0)
Proceeds and excess tax benefits from the exercise of stock options   4.7 0.4 1.4
Cash Provided by (Used in) Financing Activities   103.6 169.4 (4.1)
Effect of Exchange Rate on Cash and Cash Equivalents   0.0 0.0 0.0
Increase (Decrease) in Cash and Cash Equivalents   60.3 (38.1) (8.9)
Cash and Cash Equivalents - Beginning of Year   54.2 92.3 101.2
Cash and Cash Equivalents - End of Year 54.2 114.5 54.2 92.3
Guarantor Subsidiaries | Reportable legal entities        
Operating Activities        
Cash (Used in) Provided by Operating Activities   137.2 207.7 110.5
Investing Activities        
Capital expenditures   (32.4) (22.7) (61.3)
Acquisition of business, net of cash acquired     0.0  
Proceeds from dispositions of property   0.1 3.2 0.0
Intercompany contributions   (98.8) (177.9) (53.1)
Cash Used in Investing Activities   (131.1) (197.4) (114.4)
Financing Activities        
Intercompany contributions   0.0 0.0 0.0
Line of credit facility proceeds     0.0  
Line of credit facility repayments     0.0  
Debt repayments       0.0
Debt issuance costs     0.0  
Purchase of treasury stock   0.0 0.0 0.0
Proceeds and excess tax benefits from the exercise of stock options   0.0 0.0 0.0
Cash Provided by (Used in) Financing Activities   0.0 0.0 0.0
Effect of Exchange Rate on Cash and Cash Equivalents   0.4 (0.8) 0.0
Increase (Decrease) in Cash and Cash Equivalents   6.5 9.5 (3.9)
Cash and Cash Equivalents - Beginning of Year   9.5 0.0 3.9
Cash and Cash Equivalents - End of Year 9.5 16.0 9.5 0.0
Non-Guarantor Subsidiaries | Reportable legal entities        
Operating Activities        
Cash (Used in) Provided by Operating Activities   50.3 15.8 34.3
Investing Activities        
Capital expenditures   (10.8) (6.4) (9.1)
Acquisition of business, net of cash acquired     0.0  
Proceeds from dispositions of property   0.0 0.0 7.8
Intercompany contributions   0.0 2.7 1.3
Cash Used in Investing Activities   (10.8) (3.7) 0.0
Financing Activities        
Intercompany contributions   (2.6) (0.3) (34.6)
Line of credit facility proceeds     0.0  
Line of credit facility repayments     0.0  
Debt repayments       0.0
Debt issuance costs     0.0  
Purchase of treasury stock   0.0 0.0 0.0
Proceeds and excess tax benefits from the exercise of stock options   0.0 0.0 0.0
Cash Provided by (Used in) Financing Activities   (2.6) (0.3) (34.6)
Effect of Exchange Rate on Cash and Cash Equivalents   2.3 (1.5) (3.9)
Increase (Decrease) in Cash and Cash Equivalents   39.2 10.3 (4.2)
Cash and Cash Equivalents - Beginning of Year   50.0 39.7 43.9
Cash and Cash Equivalents - End of Year $ 50.0 $ 89.2 $ 50.0 $ 39.7